Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong · Delayed Price · Currency is HKD 15.03
-0.02 (-0.13%)
Oct 31, 2025, 4:08 PM HKT
HKG:1681 Market Cap
HKG:1681 has a market cap or net worth of 12.71 billion as of October 31, 2025. Its market cap has increased by 102.30% in one year.
Market Cap
12.71B
Enterprise Value
8.89B
Revenue
3.58B
Ranking
n/a
PE Ratio
11.65
Stock Price
15.03
Market Cap Chart
Since December 19, 2013, HKG:1681's market cap has increased from 4.90B to 12.71B, an increase of 159.46%. That is a compound annual growth rate of 8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 12.73B | 88.00% |
| Dec 31, 2024 | 6.77B | 79.14% |
| Dec 29, 2023 | 3.78B | 18.38% |
| Dec 30, 2022 | 3.19B | -8.64% |
| Dec 31, 2021 | 3.49B | 43.27% |
| Dec 31, 2020 | 2.44B | -37.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.34B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |